Imagine a truck pulling into a town fair, a university quad, or a city park—not with carnival rides, but with something arguably more valuable: a hands-on celebration of science. That’s the spirit behind Bayer’s new “Science Delivers” mobile interactive experience, a custom-built, multi-year nationwide tour that hit the road at a moment when trust in evidence feels more fragile than ever. Kicking off across the United States and running through 2027, the tour will make stops in California, Iowa, Pennsylvania, Ohio, Michigan, Indiana, Missouri, New York, New Jersey, and Washington, D.C., with more communities likely to be added along the way. The idea is refreshingly simple: instead of shouting from corporate headquarters or relying on sterile press releases, Bayer is bringing science directly to the people—to the places where they live, work, study, and gather. It’s a deliberate, somewhat brave move, because the backdrop for this journey isn’t just curiosity and discovery; it’s a landscape cluttered with viral half-truths, conspiracy theories, and fear-mongering about health and science. With so much misinformation circling the internet, Bayer wants to give Americans something real to touch, experience, and ask questions about. The mobile display itself is designed to be engaging and accessible, with interactive activities that showcase how science has delivered extraordinary progress in health, agriculture, medicine, and beyond. Tour stops will welcome scientists, farmers, researchers, students, and everyday community members into conversations that feel less like lectures and more like open dialogues. The company hopes that by meeting people where they are, they can spark genuine curiosity and help rebuild the kind of trust that has been worn down by years of digital misinformation. It’s an ambitious undertaking, but one that feels necessary in a time when basic scientific facts are often treated as matters of opinion. And while the tour is educational, it’s also emotional—it invites visitors to reflect on their own lives and the quiet ways science has shaped everything from the food on their tables to the medicines in their cabinets. Ultimately, this is not just a marketing campaign; it’s an attempt to stand up for the future of innovation by reconnecting with the public, one conversation at a time.
Step inside the mobile experience, and you’ll find a space built for engagement, not passive looking. Visitors can move through interactive displays that highlight the tangible wins of evidence-based science—the vaccines that protect communities, the crop varieties that withstand drought and disease, the breakthrough treatments for cardiovascular conditions, women’s health concerns, and everyday ailments like allergies and pain. It’s a chance to see the stories behind the headline discoveries, told in ways that make sense to non-scientists. But the experience doesn’t stop at education. Perhaps most moving is the postcard project. Guests are invited to write a physical or digital postcard sharing their own personal experiences with science—a story about a family member saved by a new medication, a farmer whose harvest improved through better seeds, a student inspired by a biology class, or a parent grateful for children’s vaccines. These postcards become part of a growing national gallery, a patchwork quilt of real human experiences that demonstrate how science isn’t abstract or remote. As of September 2026, more than 700 of these postcards have already been collected, each one a small reminder that behind every research breakthrough is a person whose life was made better. There’s something powerful about reading a neighbor’s handwritten note about how science shaped their health, their work, or their family’s future. It moves the conversation away from arguments about “trusting the experts” and toward shared experiences we can all relate to. For those who can’t visit in person, there are digital ways to participate as well, so the gallery continues to grow beyond the tour route. What makes this so effective is that it flips the script on scientific communication. Instead of telling people what to believe, it asks them to remember what science has already given them, and in doing so, helps them see why protecting and supporting research matters for the future. The postcards are both a collection of stories and a quiet, powerful form of advocacy—a way for ordinary Americans to say, with their own words and handwriting, that science has made a difference in their lives.
Bayer didn’t launch this tour on a whim or as a feel-good publicity stunt. It was prompted by a sobering piece of data. In March 2026, Bayer commissioned a Harris Poll survey of 2,023 U.S. adults titled “Science Under Siege: The Battle Between Viral Misinformation and Shared Belief in the Value of Science.” The findings were alarming, though perhaps not surprising to anyone who has spent time on social media lately. The survey found that 82% of Americans worry about their own and their families’ wellbeing due to science and health misinformation. That’s more than four out of five people—a staggering number that cuts across age, background, and political affiliation. The anxiety is real, and it’s not about isolated myths or fringe beliefs. It’s about the cumulative effect of living in a world where false claims about medicines, vaccines, farming practices, and nutrition spread faster than the truth. When you see a headline claiming a common ingredient is toxic, or a video alleging that a new medical treatment is dangerous, it’s natural to feel uneasy. The survey captures that unease and gives it a name: science under siege. For Bayer, a company built on research and innovation, this isn’t just an image problem; it’s a threat to the very foundation of scientific progress. New breakthroughs require years—sometimes decades—of painstaking research, clinical trials, and regulatory review. But that careful work can be undermined in an instant by a viral post. The result is that promising treatments may be delayed, effective vaccines may be refused, and farmers may face distrust of safe, sustainable agricultural products. The tour is a direct response to this crisis of confidence. It’s not trying to win an argument online or debunk every false claim; it’s trying to rebuild trust from the ground up, one community at a time. In a world where data and evidence are increasingly questioned, Bayer has chosen to show up in person, with interactive exhibits and open conversations, rather than retreating into corporate silence. By doing so, the company hopes to give Americans the tools they need to distinguish between credible information and misinformation, and to make decisions based on evidence rather than fear.
The voices behind the campaign make its mission clear, and their words carry the weight of people who have spent their careers in science, medicine, and research. Matthias Berninger, Bayer’s Executive Vice President and Head of Public Affairs, Sustainability, and Safety, put it bluntly: “Because misinformation threatens years of research required for new breakthroughs, we are meeting Americans where they live and work to spark curiosity and stand up for the future of innovation.” It’s a statement that acknowledges both the urgency of the problem and the humility of the solution. You can’t force someone to trust science, but you can show up, listen, and invite them to explore. Dr. Yesmean Wahdan, Senior Vice President and Head of Medical Affairs for the U.S. and North America, emphasized the human stakes: “Trust in evidence is what gets a new treatment from a trial to the person who needs it—whether that’s cardiovascular care, women’s health, or beyond. When people have access to evidence-based information they understand and trust, they make better decisions for themselves and their families. That’s what this tour is really about—meeting people where they are and giving them something solid to stand on.” Her words highlight a crucial point: scientific knowledge is only powerful if people actually understand and trust it. A breakthrough that no one accepts is just a missed opportunity. Rachel Koontz, Senior Vice President of R&D for Global Self Care at Bayer, added a practical, consumer-focused perspective: “Behind every vitamin, pain reliever or allergy treatment on a pharmacy shelf is years of rigorous science, and consumers deserve to understand and trust that work. This tour is an opportunity to close the gap between the lab and everyday life, and to give Americans the facts they need to cut through the noise.” These quotes share a common thread: the scientists and leaders at Bayer aren’t just worried about reputations or profits—they’re genuinely concerned about people. They understand that when misinformation wins, it’s real families who suffer. A parent who fears a safe vaccine puts their child at risk. A patient who distrusts evidence-backed treatments misses out on life-changing care. A farmer who is criticized for using sustainable technologies might hesitate to innovate. The tour is designed to address those fears head-on, with patience, honesty, and a willingness to listen as much as talk. It’s a reminder that behind every complicated research paper is a simple, universal goal: helping people live healthier, better lives.
The “Science Delivers” tour is just one piece of a larger movement that Bayer launched last year. The overarching campaign is an open invitation to Americans to champion the ways science has improved their lives, to recognize and combat misinformation wherever they encounter it, and to help create an environment where innovation can continue to thrive. This isn’t just about defending past achievements; it’s about making sure the next generation of breakthroughs can happen at all. Scientific research is a long, expensive, and fragile process. A society that loses faith in evidence is a society that stops investing in the future. That means fewer clinical trials, fewer promising discoveries, fewer solutions to the massive challenges we all face—from climate change to emerging diseases to feeding a growing global population. The campaign wants to flip the narrative from fear and confusion to curiosity and hope. To that end, Bayer has created an educational hub around the Science Delivers campaign, where people can learn more about tour stops, access educational resources, and share their own stories of how science has impacted their lives. Whether you visit the mobile experience in person or engage with the campaign online, you’re being invited to become part of something bigger than yourself. You can write that postcard. You can share your personal experience with science. You can talk to a friend or family member who has doubts about evidence-based medicine. Real change happens not just because a big company runs a campaign, but because regular people decide to speak up and take action. If you’ve ever benefited from a medication, a vaccine, a nutritious crop, or a medical test, then you have a story to tell. Your story might not seem dramatic, but it’s exactly the kind of story that helps others see science not as an abstract institution, but as a deeply human endeavor. The campaign’s goal is to make championing science feel natural, inclusive, and empowering—not elitist or ideological. Because at the end of the day, the future of innovation depends on a society that still believes in the power of asking questions, testing answers, and building on what works. That’s a cause everyone can support, no matter their background or beliefs.
Bayer, the force behind this ambitious effort, is already one of the world’s most recognizable names in life sciences, with a mission that is as simple as it is profound: “Health for all, Hunger for none.” With roughly 88,000 employees and sales of 45.6 billion euros in fiscal 2025, Bayer is no small player. It invests heavily in the future, spending 5.8 billion euros on research and development that year alone. But those numbers only tell part of the story. What matters more is how that investment translates into real-world impact—the medicine that calms a child’s allergy symptoms, the crop science that helps a family farm survive a difficult season, the innovations in women’s health and cardiovascular care that extend and improve lives. The Science Delivers tour is Bayer’s way of making that impact visible, tangible, and personal. It’s an acknowledgment that science isn’t just something that happens in white lab coats behind closed doors; it’s a shared human story of problem-solving and resilience. The company wants to demonstrate that science is not the enemy of everyday people—it’s a tool built by humans, for humans, to make life better. But perhaps the most human element of all is the campaign’s willingness to listen. By collecting postcards, sharing stories, and opening up conversations, Bayer is saying: we want to hear about your experiences, your hopes, your fears, and your questions. We want to learn from you as much as you learn from us. This kind of mutual respect is the foundation of trust, and trust is the foundation of progress. As the tour rolls on through 2027 and beyond, one can only hope it sparks a broader cultural shift—away from reflexive skepticism and toward thoughtful, informed engagement with science. There will always be things to question, and there should be. But there is a world of difference between healthy curiosity and destructive misinformation. The next time you see a headline designed to make you fear your medicine, your food, or your doctor, remember the postcards. Remember that science has delivered you, your family, and your community more than we often stop to appreciate. And consider writing your own story of what science has meant in your life. Because in the battle against misinformation, the most powerful weapon isn’t a corporate campaign or a viral fact-check—it’s a personal story, shared honestly and bravely, that reminds us all why we need science in the first place.